Cryptogenic stroke: Is silent atrial fibrillation the culprit?

Heart Rhythm

Volumn 12, Issue 1, 2015, Pages 234-241

  Glotzer, Taya V ^a   Ziegler, Paul D ^b  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

Atrial fibrillation; Continuous monitoring; Implantable device; Stroke

Indexed keywords

CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTABLE CARDIAC MONITOR; MULTICENTER STUDY (TOPIC); OUTPATIENT CARE; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; STROKE PATIENT; THROMBOEMBOLISM; ATRIAL FIBRILLATION; COMPLICATION; ELECTROCARDIOGRAPHY; STROKE;

ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; STROKE;

EID: 84920696626     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.09.058     Document Type: Article

References (55)

1. Mohr JP. Cryptogenic stroke. N Engl J Med 1988;318:1197-1198.
2. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-390.
3. Hart RG, Pearce LA, Aguilar MI. Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-867.
4. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly P, Themeles E, Varrone J, Wang S, Alings M, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.
5. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-992.
6. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-891.
7. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-227.
8. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2005;2:125-131.
9. Kamel H, Johnson DR, Hegde M, Go AS, Sidney S, Sorel M, Hills NK, Johnston SC. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis 2012;21:726-731.
10. Savelieva I, Camm J. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 2000;4:369-382.
11. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370:2478-2486.
12. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014;26:2467-2477.
13. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 2007;38:2935-2940.
14. Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent Holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2010;21:89-93.
15. Shafqat S, Kelly PJ, Furie KL. Holter monitoring in the diagnosis of stroke mechanism. Intern Med J 2004;34:305-309.
16. Hanke T, Charitos EI, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, Misfeld M, Sievers HH. Twenty-four-hour Holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy. Circulation 2009;120(Suppl):S177-S184.
17. Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006;3:1445-1452.
18. Tayal AH, Tian M, Kelly KM, Jones SC, Wright DG, Singh D, Jarouse J, Brillman J, Murali S, Gupta R. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology 2008;71:1696-1701.
19. Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis 2009;18:185-189.
20. Gaillard N, Deltour S, Vilotijevic B, Hornych A, Crozier S, Leger A, Frank R, Samson Y. Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology 2010;74:1666-670.
21. Bhatt A, Majid A, Razak A, Kassab M, Hussain S, Safdar A. Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring. Stroke Res Treat 2011;2011:1-5.
22. Flint AC, Banki NM, Ren X, Rao VA, Go AS. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) registry. Stroke 2012;43:2788-2790.
23. Kamel H, Navi BB, Elijovich L, Josephson SA, Yee AH, Fung G, Johnston SC, Smith WS. Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke. Stroke 2013;44:528-530.
24. Miller DJ, Khan MA, Schultz LR, Simpson JR, Katramados AM, Russman AN, Mitsiasa PD. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci 2013;324:57-61.
25. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 2013;80:1546-1550.
26. Ritter MA, Kochhäuser S, Duning T, Reinke F, Pott C, Dechering DG, Eckardt L, Ringelstein EB. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013;44:1449-1452.
27. Etgen T, Hochreiter M, Mundel M, Freudenberger T. Insertable cardiac event recorder in detection of atrial fi brillation after cryptogenic stroke: an audit report. Stroke 2013;44:2007-2009.
28. Rojo-Martinez E, Sandin M, Calleja-Sanz AI, Cortijo-Garcia E, Garcia-Bermejo P, Ruiz-Pinero M, Rubio-Sanz J, Arenillas-Lara JF. High performance of the implantable Holter in detecting occult paroxysmal AF in patients with cryptogenic stroke with a suspected embolic mechanism. Rev Neurol 2013;57:251-257.
29. Christensen LM, Krieger DW, Højberg S, Pedersen OD, Karlsen FM, Jacobsen MD, Worck R, Nielsen H, Ægidius K, Jeppesen LL, Rosenbaum S, Marstrand J, et al. Paroxysmal atrial fibrillation occurs often in cryptogenic ischemic stroke. Final results from the SURPRISE study. Eur J Neurol 2014;21:884-889.
30. Sinha AM, Diener HC, Morillo CA, Sanna T, Bernstein RA, Di Lazzaro V, Passman R, Beckers F, Brachmann J. Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J 2010;160:36-41.
31. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-129.
32. Ziegler PD, Glotzer TV, Daoud EG, Singer DE, Ezekowitz MD, Hoyt RH, Koehler JL, Coles J, Wyse DG. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. Am J Cardiol 2012;110:1309-1314.
33. Ziegler PD, Glotzer TV, Daoud EG, Wyse DG, Ezekowitz MD, Singer DE, Koehler J, Hilker C. Incidence of newly detected atrial arrhythmias via implantable devices in patients with a prior history of thromboembolic events. Stroke 2010;41:256-260.
34. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, et al. HRS/ EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2012;9:632-696.
35. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, Pürerfellner H. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrhythm Electrophysiol 2010;3:141-147.
36. Dion F, Saudeau D, Bonnaud I, Friocourt P, Bonneau A, Poret P, Giraudeau B, Régina S, Fauchier L, Babuty D. Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study. J Interv Card Electrophysiol 2010;28:101-107.
37. Ziegler PD, Sarkar S, Passman R. Ventricular rate alone is insufficient to reliably detect and quantify atrial fibrillation in insertable cardiac monitors. J Am Coll Cardiol 2014;63(12-S): A272 (abstr).
38. Kaemmerer WF, Rose MS, Mehra R. Distribution of patients' paroxysmal atrial tachyarrhythmia episodes: implications for detection of treatment efficacy. J Cardiovasc Electrophysiol 2001;12:121-130.
39. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, et al. Management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:1935-1944.
40. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-844.
41. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fi brillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.
42. Dulli DA, Stanko H, Levine RL. Atrial fi brillation is associated with severe acute ischemic stroke. Neuroepidemiology 2003;22:118-123.
43. Ziegler PD, Glotzer TV, Daoud EG, Singer DE, Ezekowitz MD, Koehler JL, Wyse DG, Coles JJ, Wyse DG. Thromboembolic event severity is associated with the presence of device-detected atrial tachyarrhythmias. Heart Rhythm 2011;8(5S):S169.
44. Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA. Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol 2007;30:404-411.
45. Cheung JW, Keating RJ, Stein KM, Markowitz SM, Iwai S, Shah BK, Lerman BB, Mittal S. Newly detected atrial fibrillation following dual chamber pacemaker implantation. J Cardiovasc Electrophysiol 2006;17:1323-1328.
46. Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol 2002;13:542-547.
47. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics sub-study of MOST. Circulation 2003;107:1614-1619.
48. Healey JS, Martin JL, Duncan A, Connolly SJ, Ha AH, Morillo CA, Nair GM, Eikelboom J, Divakaramenon S, Dokainish H. Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can J Cardiol 2013;29:224-228.
49. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-1920.
50. Botto GL, Padeletti L, Santini M, Cappucci A, Pulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009;20:241-248.
51. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythmia Electrophysiol 2009;2:474-480.
52. Shanmugam N, Boerdlein A, Proff J, Ong P, Valencia O, Maier SK, Bauer WR, Paul V, Sack S. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace 2012;14:230-237.
53. Daoud EG, Glotzer TV, Wyse DG, Ezekowitz MD, Hilker C, Koehler J, Ziegler PD. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 2011;8:1416-1423.
54. Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, Lau CP, Van Gelder IC, Hohnloser SH, Carlson M, Fain E, Nakamya J, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 2014;129:2094-2099.
55. Martin DT. Randomized trial of anticoagulation guided by remote rhythm monitoring in patients with implanted cardioverter-defibrillator and resynchronization devices. ACC Scienti fic Session, Washington, DC, March 2014.